{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T06:48:02Z","timestamp":1767422882127},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Biotechnology (DBT, Govt. of India)"},{"name":"Center for Scientific and Industrial Research (CSIR), New Delhi"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.exppara.2011.05.014","type":"journal-article","created":{"date-parts":[[2011,5,27]],"date-time":"2011-05-27T13:24:23Z","timestamp":1306502663000},"page":"55-64","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy of Leishmania donovani ribosomal P1 gene as DNA vaccine in experimental visceral leishmaniasis"],"prefix":"10.1016","volume":"129","author":[{"given":"Shet","family":"Masih","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil K.","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh K.","family":"Vasishta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2011.05.014_b0005","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/icb.1995.69","article-title":"Lack of serological specificity of recombinant heat shock protein of Leishmania donovani","volume":"73","author":"Arora","year":"1995","journal-title":"Immunology and Cell Biology"},{"key":"10.1016\/j.exppara.2011.05.014_b0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.exppara.2004.12.009","article-title":"Leishmania donovani: identification of novel vaccine candidates using human reactive sera and cell lines","volume":"109","author":"Arora","year":"2005","journal-title":"Experimental Parasitology"},{"key":"10.1016\/j.exppara.2011.05.014_b0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.exppara.2008.09.019","article-title":"Vaccination with a novel recombinant Leishmania antigen along with MPL provides partial protection against L. donovani challenge in experimental model of visceral leishmaniasis","volume":"121","author":"Bhardwaj","year":"2009","journal-title":"Experimental Parasitology"},{"key":"10.1016\/j.exppara.2011.05.014_b0020","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/eji.1830200528","article-title":"Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes","volume":"20","author":"Bogdan","year":"1990","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.exppara.2011.05.014_b0025","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the Quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal of Biochemistry"},{"key":"10.1016\/j.exppara.2011.05.014_b0030","first-page":"427","article-title":"Hypergammaglobulinaemia in Leishmania donovani infected hamsters: possible association with a polyclonal activator of B cells with suppression of T cell function","volume":"59","author":"Bunn-Moreno","year":"1985","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.exppara.2011.05.014_b0035","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1172\/JCI112209","article-title":"Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis","volume":"76","author":"Carvalho","year":"1985","journal-title":"Journal of Clinical Investigations"},{"key":"10.1016\/j.exppara.2011.05.014_b0040","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","article-title":"Second-generation vaccines against leishmaniasis","volume":"21","author":"Coler","year":"2005","journal-title":"Trends in Parasitology"},{"key":"10.1016\/j.exppara.2011.05.014_b0045","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0264-410X(98)00338-7","article-title":"Evaluation of the stability and immunogenicity of autoclaved and non autoclaved preparations of a vaccine against American integumentary leishmaniasis","volume":"17","author":"De Luca","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2011.05.014_b0050","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1051\/vetres:2005033","article-title":"Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis","volume":"36","author":"Fujiwara","year":"2005","journal-title":"Veterinary Research"},{"key":"10.1016\/j.exppara.2011.05.014_b0055","first-page":"318","article-title":"Serological investigations on Indian kala-azar","volume":"40","author":"Ghose","year":"1980","journal-title":"Clinical and Experimantal Immunology"},{"key":"10.1016\/j.exppara.2011.05.014_b0060","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/IAI.57.10.3091-3096.1989","article-title":"Comparison of T-cell responses in self\u2013limiting versus progressive visceral Leishmania donovani infections in golden hamsters","volume":"57","author":"Gifawesen","year":"1989","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.exppara.2011.05.014_b0065","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1016\/j.vaccine.2005.07.001","article-title":"Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals","volume":"23","author":"Gradoni","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2011.05.014_b0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmaniasis: Current Status of Vaccine Development","volume":"14","author":"Handman","year":"2001","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1016\/j.exppara.2011.05.014_b0075","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1365-2567.2000.00025.x","article-title":"Inflammatory cytokine production by immunological and foreign body multinucleated giant cells","volume":"100","author":"Hernandez-Pando","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.exppara.2011.05.014_b0080","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.exppara.2011.05.014_b0085","first-page":"79","article-title":"Immunological regulation and control of experimental leishmaniasis","volume":"28","author":"Howard","year":"1986","journal-title":"International Reviews in Experimental Pathology"},{"key":"10.1016\/j.exppara.2011.05.014_b0090","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.1128\/IAI.71.11.6562-6572.2003","article-title":"The Leishmania infantum acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to Leishmania major infection in BALB\/c mice","volume":"71","author":"Iborra","year":"2003","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.exppara.2011.05.014_b0095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1017\/S0031182006001831","article-title":"Leishmania vaccines: progress and problems","volume":"133","author":"Kedzierski","year":"2006","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2011.05.014_b0100","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(00)03128-7","article-title":"Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan","volume":"356","author":"Khalil","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.exppara.2011.05.014_b0105","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0169-4758(93)90088-W","article-title":"The Trypanosomacruzi ribosomal P protein family: classification and antigenicity","volume":"9","author":"Levin","year":"1993","journal-title":"Parasitology Today"},{"key":"10.1016\/j.exppara.2011.05.014_b0110","first-page":"731","article-title":"Immunity: Clinical and experimental","volume":"vol. 2","author":"Mauel","year":"1987"},{"key":"10.1016\/j.exppara.2011.05.014_b0115","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/IAI.66.5.2135-2142.1998","article-title":"Cloning of syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis","volume":"66","author":"Melby","year":"1998","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.exppara.2011.05.014_b0120","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/AAC.45.8.2185-2197.2001","article-title":"Clinical and experimental advances in treatment of visceral leishmaniasis","volume":"45","author":"Murray","year":"2001","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.exppara.2011.05.014_b0125","series-title":"Inflammation: Basic Principles and Clinical Correlates","first-page":"977","article-title":"Granulomatous inflammation: host antimicrobial defense in the tissues in visceral leishmaniasis","author":"Murray","year":"1999"},{"key":"10.1016\/j.exppara.2011.05.014_b0130","first-page":"47","article-title":"Recognition of Leishmania donovani by CD4+ T cells of naive healthy uninfected individuals","volume":"27","author":"Pal","year":"2003","journal-title":"Journal of Parasitic Diseases"},{"key":"10.1016\/j.exppara.2011.05.014_b0140","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1002\/eji.1830271024","article-title":"A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-a production and expression of B7\u20131 in human Monocyte derived antigen presenting cells","volume":"27","author":"Probst","year":"1997","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.exppara.2011.05.014_b0145","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0952-7915(03)00069-4","article-title":"Vaccines for parasitic and bacterial diseases","volume":"15","author":"Reed","year":"2003","journal-title":"Current Opinions in Immunology"},{"key":"10.1016\/j.exppara.2011.05.014_b0150","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1517\/14712598.4.9.1505","article-title":"Recent advances in vaccines for leishmaniasis","volume":"4","author":"Requena","year":"2004","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1016\/j.exppara.2011.05.014_b0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-3024.1992.tb00005.x","article-title":"Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens","volume":"14","author":"Rodrigues","year":"1992","journal-title":"Parasite Immunology"},{"key":"10.1016\/j.exppara.2011.05.014_b0160","doi-asserted-by":"crossref","first-page":"908","DOI":"10.4049\/jimmunol.138.3.908","article-title":"An analysis of T cell responsiveness in Indian kala-azar","volume":"138","author":"Sacks","year":"1987","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.exppara.2011.05.014_b0170","series-title":"Molecular cloning\u2013A laboratory Manual","author":"Sambrook","year":"2001"},{"key":"10.1016\/j.exppara.2011.05.014_b0175","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1046\/j.1440-1711.2000.00933.x","article-title":"Restraining mycobacteria- role of granulomas in mycobacterial infections","volume":"78","author":"Saunders","year":"2000","journal-title":"Immunology and Cell Biology"},{"key":"10.1016\/j.exppara.2011.05.014_b0180","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(98)09552-X","article-title":"Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran","volume":"351","author":"Sharifi","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.exppara.2011.05.014_b0185","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1128\/IAI.62.5.1643-1651.1994","article-title":"Antigens shared by Leishmania species and Trypanosoma cruzi: immunological comparison of the acidic ribosomal P0 proteins","volume":"62","author":"Skeiky","year":"1994","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.exppara.2011.05.014_b0190","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.4049\/jimmunol.161.11.6171","article-title":"LeIF: a recombinant Leishmania protein that induces an IL-12 mediated TH1 cytokine profile","volume":"161","author":"Skeiky","year":"1998","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.exppara.2011.05.014_b0195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-2478(95)02436-0","article-title":"Identification of the Leishmania infantumP0 ribosomal protein epitope in canine visceral leishmaniasis","volume":"48","author":"Soto","year":"1995","journal-title":"Immunology Letters"},{"key":"10.1016\/j.exppara.2011.05.014_b0200","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1550-7408.1958.tb02565.x","article-title":"An eight day method for screening compounds against Leishmania donovani in the golden hamster","volume":"5","author":"Stauber","year":"1958","journal-title":"Journal of Protozoology"},{"key":"10.1016\/j.exppara.2011.05.014_b0205","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.4049\/jimmunol.175.4.2517","article-title":"IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection","volume":"175","author":"Stober","year":"2005","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.exppara.2011.05.014_b0210","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1128\/IAI.70.5.2288-2296.2002","article-title":"Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp","volume":"70","author":"Travi","year":"2002","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.exppara.2011.05.014_b0215","unstructured":"Vasconcellos RCS, Urago KP, Bunn-Moreno MM Madeira ED., 1996. Suppressor activity in Leishmania donovani-infected hamster serum: reversion by delipidated bovine serum albumin and role in cell cycle events. Brazilian Journal of Medical and Biological Research 29: 615-622. WHO Technical Report Series, 2000."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489411001639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489411001639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T03:05:42Z","timestamp":1686107142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489411001639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0014489411001639"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2011.05.014","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}